Detalhe da pesquisa
1.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood
; 143(16): 1616-1627, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215395
2.
DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia.
Genome Res
; 31(5): 747-761, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707228
3.
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.
Blood
; 137(25): 3473-3483, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33754642
4.
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
Blood
; 138(17): 1570-1582, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424958
5.
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A.
Proc Natl Acad Sci U S A
; 117(42): 26340-26346, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020282
6.
The present and future of measurable residual disease testing in acute myeloid leukemia.
Haematologica
; 107(12): 2810-2822, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453518
7.
Constitutively Active Androgen Receptor in Hepatocellular Carcinoma.
Int J Mol Sci
; 23(22)2022 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430245
8.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
N Engl J Med
; 379(26): 2517-2528, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501481
9.
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
Blood
; 134(8): 688-698, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292113
10.
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML.
Invest New Drugs
; 38(2): 340-349, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102119
11.
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Am J Hematol
; 95(12): 1457-1465, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777116
12.
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
Proc Natl Acad Sci U S A
; 114(36): 9629-9634, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28827320
13.
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Blood
; 129(5): 553-560, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903528
14.
Targeting BTK through microRNA in chronic lymphocytic leukemia.
Blood
; 128(26): 3101-3112, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756747
15.
A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485.
Haematologica
; 103(6): 982-987, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567781
16.
Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis.
Am J Hematol
; 98(5): E116-E118, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808760
17.
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.
Proc Natl Acad Sci U S A
; 112(14): 4322-7, 2015 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25787252
18.
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
J Biol Chem
; 291(49): 25656-25666, 2016 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780867
19.
MuCor: mutation aggregation and correlation.
Bioinformatics
; 32(10): 1557-8, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26803155
20.
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations.
Blood
; 135(24): 2192-2195, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232486